{"id":54470,"date":"2023-03-03T14:05:43","date_gmt":"2023-03-03T13:05:43","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\/"},"modified":"2023-03-03T14:05:43","modified_gmt":"2023-03-03T13:05:43","slug":"bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\/","title":{"rendered":"Bioceres Crop Solutions Announces Brazil\u00b4s Regulatory Approval of Drought Tolerant HB4\u00ae Wheat for Commercialization and Cultivation"},"content":{"rendered":"
\n

ROSARIO, Argentina–(BUSINESS WIRE)–Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX),<\/b> a fully integrated global provider of crop productivity solutions designed to enable the transition of agriculture toward carbon neutrality, announced today that CTNBio, the National Biosafety Commission of Brazil\u00b4s Ministry of Science, Technology, and Innovation, has concluded the safety evaluation of HB4 Wheat, providing full approval for commercialization and cultivation in Brazil.\n<\/p>\n

\nToday\u2019s approval builds on Brazil\u2019s previous approval for food and feed use of HB4 Wheat flour in November 2021. In addition to opening the Brazilian market to the technology, the decision clears the path for commercialization in Argentina through channels other than Bioceres\u2019 identity-preserved HB4 Program.\n<\/p>\n

\nThe approval also enables the acceleration of Bioceres\u2019 collaboration with EMBRAPA (Brazil\u2019s Agricultural Research Corporation) to develop subtropical wheat varieties to increase the supply of local materials in this geography. HB4 Wheat offers the potential for double cropping \u2013 rotating wheat with a summer legume \u2013 in regions of the country that are currently limited by water availability.\n<\/p>\n

\nThe HB4 technology is a key tool in the adaptation of farming systems to a more extreme climate, having already proven to deliver more than 40% yield increases in environments under severe water stress, based on results from Argentina\u2019s recent drought-affected crop. This approval paves the way for the technology to deliver $15-$20 million in incremental EBITDA by FY24, as previously communicated.\n<\/p>\n

\nBrazil is the second country where regulatory agencies have cleared HB4 Wheat for cultivation, after Argentina, and completes the approval processes for the company\u00b4s wheat target markets in Latin America. Brazil plants 2-3 million hectares of wheat annually and, together, both countries plant 90% of South America\u2019s wheat acreage. HB4 Wheat is also approved for food and feed use in the United States, Colombia, New Zealand, Australia, South Africa and Nigeria, and for feed use in Indonesia.\n<\/p>\n

\nAbout Bioceres Crop Solutions Corp.<\/b>\n<\/p>\n

\nBioceres Crop Solutions Corp. (NASDAQ: BIOX) is a fully integrated provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. To do this, Bioceres\u2019 solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices. The Company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. Through its HB4 program, the Company is bringing digital solutions to support growers\u2019 decisions and provide end-to-end traceability for production outputs. For more information, visit here<\/a>.\n<\/p>\n

\nForward-looking statements<\/b>\n<\/p>\n

\nThis communication includes \u201cforward-looking statements\u201d within the meaning of the \u201csafe harbor\u201d provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as \u201cforecast,\u201d \u201cintend,\u201d \u201cseek,\u201d \u201ctarget,\u201d \u201canticipate,\u201d \u201cbelieve,\u201d \u201cexpect,\u201d \u201cestimate,\u201d \u201cplan,\u201d \u201coutlook,\u201d and \u201cproject\u201d and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements are based on management\u2019s reasonable current assumptions, expectations, plans and forecasts regarding the Company\u2019s current or future results and future business and economic conditions more generally. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, levels of activity, performance or achievement of the Company to be materially different from any future results expressed or implied by such forward-looking statements, and there can be no assurance that actual results will not differ materially from management\u2019s expectations or could affect the Company\u2019s ability to achieve its strategic goals, including the uncertainties relating to the impact of COVID-19 on the Company\u2019s business, operations, liquidity and financial results and the other factors that are described in the sections entitled \u201cRisk Factors\u201d in the Company’s Securities and Exchange Commission filings updated from time to time. The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. Therefore, you should not rely on any of these forward-looking statements as predictions of future events. All forward-looking statements contained in this release are qualified in their entirety by this cautionary statement. Forward-looking statements speak only as of the date they are or were made, and the Company does not intend to update or otherwise revise the forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, except as required by law.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nBioceres Crop Solutions<\/b>
Paula Savanti
\n
Head of Investor Relations
\n
investorrelations@biocerescrops.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

ROSARIO, Argentina–(BUSINESS WIRE)–Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a fully integrated global provider of crop productivity solutions designed to enable the transition of agriculture toward carbon neutrality, announced today that CTNBio, the National Biosafety Commission of Brazil\u00b4s Ministry of Science, Technology, and Innovation, has concluded the safety evaluation of HB4 Wheat, providing full approval … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54470","6":"format-standard","7":"category-industry"},"yoast_head":"\nBioceres Crop Solutions Announces Brazil\u00b4s Regulatory Approval of Drought Tolerant HB4\u00ae Wheat for Commercialization and Cultivation - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bioceres Crop Solutions Announces Brazil\u00b4s Regulatory Approval of Drought Tolerant HB4\u00ae Wheat for Commercialization and Cultivation - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ROSARIO, Argentina–(BUSINESS WIRE)–Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a fully integrated global provider of crop productivity solutions designed to enable the transition of agriculture toward carbon neutrality, announced today that CTNBio, the National Biosafety Commission of Brazil\u00b4s Ministry of Science, Technology, and Innovation, has concluded the safety evaluation of HB4 Wheat, providing full approval ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-03T13:05:43+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Bioceres Crop Solutions Announces Brazil\u00b4s Regulatory Approval of Drought Tolerant HB4\u00ae Wheat for Commercialization and Cultivation\",\"datePublished\":\"2023-03-03T13:05:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\\\/\"},\"wordCount\":753,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\\\/\",\"name\":\"Bioceres Crop Solutions Announces Brazil\u00b4s Regulatory Approval of Drought Tolerant HB4\u00ae Wheat for Commercialization and Cultivation - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2023-03-03T13:05:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bioceres Crop Solutions Announces Brazil\u00b4s Regulatory Approval of Drought Tolerant HB4\u00ae Wheat for Commercialization and Cultivation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bioceres Crop Solutions Announces Brazil\u00b4s Regulatory Approval of Drought Tolerant HB4\u00ae Wheat for Commercialization and Cultivation - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\/","og_locale":"en_US","og_type":"article","og_title":"Bioceres Crop Solutions Announces Brazil\u00b4s Regulatory Approval of Drought Tolerant HB4\u00ae Wheat for Commercialization and Cultivation - Pharma Trend","og_description":"ROSARIO, Argentina–(BUSINESS WIRE)–Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a fully integrated global provider of crop productivity solutions designed to enable the transition of agriculture toward carbon neutrality, announced today that CTNBio, the National Biosafety Commission of Brazil\u00b4s Ministry of Science, Technology, and Innovation, has concluded the safety evaluation of HB4 Wheat, providing full approval ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-03T13:05:43+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Bioceres Crop Solutions Announces Brazil\u00b4s Regulatory Approval of Drought Tolerant HB4\u00ae Wheat for Commercialization and Cultivation","datePublished":"2023-03-03T13:05:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\/"},"wordCount":753,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\/","url":"https:\/\/pharma-trend.com\/en\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\/","name":"Bioceres Crop Solutions Announces Brazil\u00b4s Regulatory Approval of Drought Tolerant HB4\u00ae Wheat for Commercialization and Cultivation - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2023-03-03T13:05:43+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bioceres-crop-solutions-announces-brazils-regulatory-approval-of-drought-tolerant-hb4-wheat-for-commercialization-and-cultivation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Bioceres Crop Solutions Announces Brazil\u00b4s Regulatory Approval of Drought Tolerant HB4\u00ae Wheat for Commercialization and Cultivation"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54470"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54470\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54470"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54470"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}